CA125

You have access
Matrix Metalloproteinase-1 as an Independent Prognostic Biomarker in Epithelial Ovarian Carcinoma
KOHEI HIKINO, HIROAKI KOMATSU, YASUHIRO KAZUKI, KANAKO KAZUKI, KOJI YAMAMOTO, MASAYO OKAWA, YUKI IIDA, MAYUMI SAWADA, GENKI HICHIWA, SHINYA SATO, HIROYUKI KUGOH, MITSUO OSHIMURA, TASUKU HARADA and FUMINORI TANIGUCHI

Anticancer Research October 2025, 45 (10) 4473-4481; DOI: https://doi.org/10.21873/anticanres.17795
You have access
Screening for Ovarian Cancer in the General Population: State of Art and Perspectives of Clinical Research
ANGIOLO GADDUCCI and STEFANIA COSIO

Anticancer Research September 2022, 42 (9) 4207-4216; DOI: https://doi.org/10.21873/anticanres.15921
You have access
Effects of Pegylated Liposomal Doxorubicin and CA125 Level Variability Analysis in Platinum-refractory/resistant Recurrent Ovarian Cancer
TAKUMA OOYAMA, YUKO SHIMOJI, TADAHARU NAKASONE, YOSHIHISA ARAKAKI, YUSUKE TAIRA, TOMOKO NAKAMOTO, WATARU KUDAKA and YOICHI AOKI

Anticancer Research June 2022, 42 (6) 3017-3022; DOI: https://doi.org/10.21873/anticanres.15786
You have access
Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management
JIRI PRESL, PETRA OVESNA, ZDENEK NOVOTNY, PAVEL VLASAK, JIRI BOUDA, JAN KOSTUN, ONDREJ TOPOLCAN, RADEK KUCERA, MARKETA BEDNARIKOVA and VIT WEINBERGER

Anticancer Research May 2017, 37 (5) 2697-2702;
You have access
Implementing the Risk of Ovarian Malignancy Algorithm Adding Obesity as a Predictive Factor
EMANUELA ANASTASI, DANILA CAPOCCIA, TERESA GRANATO, GIANFRANCO SILECCHIA, MARIO RIZZELLO, MARIA GRAZIA PORPORA, LUIGI FRATI, ANTONIO ANGELONI and FRIDA LEONETTI

Anticancer Research December 2016, 36 (12) 6425-6429;
You have access
Dynamic Analysis of CA125 Decline During Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer as a Predictor for Platinum Sensitivity
AURÉLIE PELISSIER, CLAIRE BONNEAU, ELISABETH CHÉREAU, THIBAULT DE LA MOTTE ROUGE, VIRGINIE FOURCHOTTE, EMILE DARAÏ and ROMAN ROUZIER

Anticancer Research April 2016, 36 (4) 1865-1871;
You have access
Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy
YA RUTH HUO, YEQIAN HUANG, WINSTON LIAUW, JING ZHAO and DAVID L. MORRIS

Anticancer Research March 2016, 36 (3) 1041-1049;
You have access
A Biomarker Panel Increases the Diagnostic Performance for Epithelial Ovarian Cancer Type I and II in Young Women
PIA LEANDERSSON, GRIGORIOS KALAPOTHARAKOS, EMIR HENIC, HENRIK BORGFELDT, MAX PETZOLD, GUNILLA HØYER-HANSEN and CHRISTER BORGFELDT

Anticancer Research March 2016, 36 (3) 957-965;
You have access
Biparametric Magnetic Resonance Imaging as an Adjunct to CA125 and HE4 to Improve Characterization of Large Ovarian Masses
LUCIA MANGANARO, EMANUELA ANASTASI, MARIA GRAZIA PORPORA, VALERIA VINCI, MATTEO SALDARI, SILVIA BERNARDO, LAURA BALLESIO, PAOLO SOLLAZZO, IRENE PECORELLA, NICOLA RECCHIA, FABRIZIO STRACCI, PIERLUIGI BENEDETTI PANICI, ANTONIO ANGELONI, CARLO CATALANO and MICHELE SCIALPI

Anticancer Research November 2015, 35 (11) 6341-6351;
You have access
Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites
JAUME TRAPÉ, GABRIEL GURT, JOSEFINA FRANQUESA, JESÚS MONTESINOS, ANNA ARNAU, MARIA SALA, FRANCESC SANT, ESTHER CASADO, JOSEP MARIA ORDEIG, CARMEN BERGOS, FRANCESC VIDA, PAU SORT, ÁLVARO ISAVA, MONTSERRAT GONZÁLEZ and RAFAEL MOLINA

Anticancer Research October 2015, 35 (10) 5655-5660;

Main menu

User menu

Search

CA125

Pages